Skip to Content


Rebecca Robins, quoting Rachel E. Sachs (Academic Fellow Alumna)
STAT News
June 27, 2017

Read the Full Article

From the article:

The Food and Drug Administration on Tuesday moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices.

In a policy change, the agency will now fast-track applications for generic drugs until three of them have been approved for a given medication. And in a broadcast to manufacturers about what it’s looking for, the FDA also published a list of about 170 categories of old drugs without generics, ranging from a glaucoma drug to the penicillin antibiotic amoxicillin.

Read the full article here.

Read the Full Article

Tags

bioethics   fda   health law policy   pharmaceuticals   public health   rachel sachs   regulation